TRAJENTA TABLET 5MG ( LINAGLIPTIN ) increases insulin and lowers glucagon production. This results in a reduction of the blood glucose levels.
Side effects
Major & minor side effects for TRAJENTA TABLET 5MG ( LINAGLIPTIN )

Anxiety

Blurred vision

Confusion

Depression

Fast heartbeat

Headache

Nausea

Increased hunger

Slurred speech

Chills

Unusual tiredness or weakness

Uses of TRAJENTA TABLET 5MG ( LINAGLIPTIN )
What is it prescribed for?

Type II Diabetes Mellitus
This medicine reduces blood glucose levels in patients with type II diabetes mellitus.

Concerns

Frequently asked questions

Onset of action
The amount of time required for this medicine to show its action is not clinically established.

Duration of Effect
The amount of time for which this medicine remains active in the body is not clinically established.

Safe with Alchohol?
Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.

Is it habit forming?
No habit forming tendency has been reported.

Usage in pregnancy?
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to TRAJENTA TABLET 5MG ( LINAGLIPTIN ) or any other inactive ingredients present along with it.

Type 1 Diabetes mellitus
This medicine is not recommended for use in patients with type 1 diabetes mellitus since it is not effective in treating this condition.

Diabetic ketoacidosis
This medicine is not recommended for use in patients with a known history of diabetic ketoacidosis due to the increased risk of worsening of the patient’s condition.

Warnings

Warnings for special population

Pregnancy
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

General Warnings

Insulin secreagogues
This medicine should be used with caution in patients who are using insulin secretagogues due to the increased risk of hypoglycemia. Close monitoring of blood sugar levels is recommended for such patients. Appropriate dose adjustments may be necessary based on the clinical condition.

Bullous pemphigoid
This medicine should be used with caution due to the increased risk of bullous pemphigoid, a hypersensitivity reaction of the skin. Any unusual symptoms such as skin blisters or skin rashes should be reported to the doctor on priority. Therapy with the medicine may be discontinued based on the clinical condition of the patient.

Arthralgia
This medicine should be used with caution in patients with a known history of severe arthralgia due to the increased risk of worsening of the patient’s condition. Close monitoring of patient’s condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Type 1 diabetes mellitus
This medicine is not recommended for use in patients with a known history of type 1 diabetes mellitus since it is not effective in treating this condition.

Use in pediatrics
This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.

Dosage

Missed Dose
Take the missed dose as soon as you remember it. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions
Interaction with Medicines

Aripiprazole moderate

Clozapine moderate

Dexamethasone moderate

Dopamine moderate

Acetazolamide moderate

Gatifloxacin severe

Bexarotene severe

Disease interactions

severe
This medicine should be used with extreme caution in patients with a known history of pancreatitis due to the increased risk of recurrent pancreatitis. Report any symptoms such as abdominal pain, nausea, vomiting, etc. to the doctor immediately. Therapy with the medicine may be discontinued based on the clinical condition of the patient.

General Instructions

Take this medicine exactly as instructed by the doctor. It can be taken with or without food. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor.

Other details

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

References

medlineplus –
Linagliptin [Internet].
Available from: https://medlineplus.gov/druginfo/meds/a611036.html
[cited 2/6/2021].
2021